1. 109P Impact of anti-drug antibody (ADA) on naxitamab efficacy and safety. (December 2022) Authors: Kushner, B.; Chan, G.C.; Morgenstern, D.A.; Amoroso, L.; Nysom, K.; Faber, J.; Wingerter, A.; Bear, M.; Rubio San Simon, A.; Tornøe, K.; Sørensen, P.S.; Mora, J. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 62MO Naxitamab pivotal clinical trial planned interim analysis of PFS and OS in patients with relapsed or refractory high-risk neuroblastoma. (December 2022) Authors: Mora, J.; Chan, G.C.; Morgenstern, D.A.; Amoroso, L.; Nysom, K.; Faber, J.; Wingerter, A.; Bear, M.; Rubio San Simon, A.; Tornøe, K.; Sørensen, P.S.; Kushner, B. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LBA3 Compartmental radioimmunotherapy (cRIT) 131I-OMBURTAMAB in patients with neuroblastoma (NB) central nervous system (CNS) and/or leptomeningeal (LM) metastases: Updated results from pivotal Trial 101. (December 2022) Authors: Basu, E.; Mora, J.; Streby, K.; Bear, M.; Sano, H.; Marachelian, A.; Harrison, D.; Nysom, K.; Pandit-Taskar, N.; Zanzonico, P.; Fabricius, S.; During, M.; Nielsen, J.R.; Kramer, K. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-0761 Reirradiation of pediatric patients with diffuse midline glioma. (May 2022) Authors: Østergaard, D.; Vogelius, I.R.; Mathiasen, R.; Nysom, K.; Jørgensen, M.; Sehested, A.M.; Maraldo, M. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S676 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PD-0165 The risk of neurocognitive impairment and the impact of sparing the hippocampus during pediatric CSI. (May 2022) Authors: Gram, D.; Brodin, P.; Björk-Eriksson, T.; Nysom, K.; Munck af Rosenschöld, P. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-0990 Positioning uncertainties for pediatric craniospinal irradiation and the impact of image guidance. (April 2019) Authors: Gasic, D.; Haraldsson, A.; Brodin, N.P.; Nysom, K.; Björk-Eriksson, T.; Rosenschöld, P. Munck Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗